5 Cardiomyopathy Clinical Trials in Chicago, IL (2026)

Q: How do I join a clinical trial in Chicago?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you.

Recruiting Cardiomyopathy Studies in Chicago

NCT00138931Recruiting

Genetics of Cardiovascular and Neuromuscular Disease

We are studying the genetics of human cardiovascular and neuromuscular disease. There are many different genetic regions that have been associated with the development of cardiomyopathy. An equal numb...

Chicago, IL2,000 participantsUniversity of Chicago

View Study Details

NCT07210723Recruiting

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

The Sponsor is studying an investigational medication called danicamtiv to determine if it can help people with genetic and familial dilated cardiomyopathy (DCM). Investigational means that the safety...

Chicago, IL332 participantsKardigan, Inc.

View Study Details

NCT07608354Recruiting

A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM

The purpose of this randomised, double-blind, placebo-controlled, multicenter study is to evaluate the efficacy and safety of concomitant use of eplontersen and ALXN2220 compared with eplontersen and ...

Chicago, IL326 participantsAstraZeneca

View Study Details

NCT07023614Recruiting

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

FORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and safety of ninerafaxstat compared to placebo on top of Standard...

Chicago, IL165 participantsImbria Pharmaceuticals, Inc.

View Study Details

NCT06412666Recruiting

A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

The purpose of this study is to evaluate the efficacy, safety and PK of aficamten in a pediatric population with symptomatic obstructive hypertrophic cardiomyopathy (oHCM)....

Chicago, IL55 participantsCytokinetics

View Study Details

About Cardiomyopathy Clinical Trials in Chicago

Cardiomyopathy refers to diseases of the heart muscle that make it harder for the heart to pump blood. Types include dilated, hypertrophic, and restrictive cardiomyopathy. Treatment depends on the type and may include medications, devices, or heart transplant.

There are currently 5 cardiomyopathy clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 2,878 participants. Research is being sponsored by University of Chicago, Kardigan, Inc., AstraZeneca and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Cardiomyopathy Clinical Trials in Chicago — FAQ

Are there cardiomyopathy clinical trials in Chicago?

Yes, there are 5 cardiomyopathy clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chicago?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.

Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.

What cardiomyopathy treatments are being tested?

The 5 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for cardiomyopathy.

Data updated July 13, 2026 from ClinicalTrials.gov